Douglas O. Escrivani
Chalcones identify cTXNPx as a potential antileishmanial drug target
Escrivani, Douglas O.; Charlton, Rebecca L.; Caruso, Marjolly B.; Burle-Caldas, Gabriela A.; Borsodi, Maria Paula G.; Zingali, Russolina B.; Arruda-Costa, Natalia; Palmeira-Mello, Marcos V.; de Jesus, Jéssica B.; Souza, Alessandra M.T.; Abrahim-Vieira, Bárbara; Freitag-Pohl, Stefanie; Pohl, Ehmke; Denny, Paul W.; Rossi-Bergmann, Bartira; Steel, Patrick G.
Authors
Rebecca L. Charlton
Marjolly B. Caruso
Gabriela A. Burle-Caldas
Maria Paula G. Borsodi
Russolina B. Zingali
Natalia Arruda-Costa
Marcos V. Palmeira-Mello
Jéssica B. de Jesus
Alessandra M.T. Souza
Bárbara Abrahim-Vieira
Dr Stefanie Freitag Pohl stefanie.freitag-pohl@durham.ac.uk
Assistant Professor (Research)
Professor Ehmke Pohl ehmke.pohl@durham.ac.uk
Interim Director
Professor Paul Denny p.w.denny@durham.ac.uk
Professor
Bartira Rossi-Bergmann
Patrick G. Steel
Abstract
With current drug treatments failing due to toxicity, low efficacy and resistance; leishmaniasis is a major global health challenge that desperately needs new validated drug targets. Inspired by activity of the natural chalcone 2’,6’-dihydroxy-4’-methoxychalcone (DMC), the nitro-analogue, 3-nitro-2’,4’,6’- trimethoxychalcone (NAT22, 1c) was identified as potent broad spectrum antileishmanial drug lead. Structural modification provided an alkyne containing chemical probe that labelled a protein within the parasite that was confirmed as cytosolic tryparedoxin peroxidase (cTXNPx). Crucially, labelling is observed in both promastigote and intramacrophage amastigote life forms, with no evidence of host macrophage toxicity. Incubation of the chalcone in the parasite leads to ROS accumulation and parasite death. Deletion of cTXNPx, by CRISPR-Cas9, dramatically impacts upon the parasite phenotype and reduces the antileishmanial activity of the chalcone analogue. Molecular docking studies with a homology model of in-silico cTXNPx suggest that the chalcone is able to bind in the putative active site hindering access to the crucial cysteine residue. Collectively, this work identifies cTXNPx as an important target for antileishmanial chalcones.
Citation
Escrivani, D. O., Charlton, R. L., Caruso, M. B., Burle-Caldas, G. A., Borsodi, M. P. G., Zingali, R. B., …Steel, P. G. (2021). Chalcones identify cTXNPx as a potential antileishmanial drug target. PLoS Neglected Tropical Diseases, 15(11), Article e0009951. https://doi.org/10.1371/journal.pntd.0009951
Journal Article Type | Article |
---|---|
Acceptance Date | Oct 26, 2021 |
Online Publication Date | Nov 1, 2021 |
Publication Date | 2021 |
Deposit Date | Nov 16, 2021 |
Publicly Available Date | Jan 17, 2022 |
Journal | PLOS Neglected Tropical Diseases |
Print ISSN | 1935-2727 |
Publisher | Public Library of Science |
Peer Reviewed | Peer Reviewed |
Volume | 15 |
Issue | 11 |
Article Number | e0009951 |
DOI | https://doi.org/10.1371/journal.pntd.0009951 |
Public URL | https://durham-repository.worktribe.com/output/1221783 |
Files
Published Journal Article
(3 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Copyright Statement
© 2021 Escrivani et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
You might also like
Derisking the Polymorph Landscape: The Complex Polymorphism of Mexiletine Hydrochloride
(2021)
Journal Article
Going to extremes - a metagenomic journey into the dark matter of life
(2021)
Journal Article
Downloadable Citations
About Durham Research Online (DRO)
Administrator e-mail: dro.admin@durham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search